VIEW PCV STUDIES
Question Evidence-Based, Logic-Driven Response (PCV)
What is my child’s actual risk of dying from this disease, statistically? Streptococcus pneumoniae can cause meningitis or sepsis, but mortality in healthy, full-term U.S. infants is extremely rare. Most severe cases pre-vaccine occurred in immunocompromised children or those in poor living conditions. By the 1990s, prior to PCV's 2000 introduction, deaths had already declined sharply due to antibiotics and medical care.
Have you lost an unvaccinated patient to pneumococcal disease? Any patient lost due to the vaccine? Most pediatricians practicing post-2000 have never seen a fatal case of pneumococcal disease in a healthy child. However, VAERS contains hundreds of reports of death following PCV vaccination, often within days, especially when given with other shots.
Odds of any side effect? Severe side effect? Compared to disease mortality? - Mild: pain at injection site, fever, irritability (~30%).
- Severe: seizures, high-pitched screaming, apnea, death (documented).
- Mortality from natural pneumococcus in the U.S. (with prompt treatment): near zero in healthy infants. Risk from vaccine (VAERS + post-market data): non-zero, underreported.
Most severe adverse event you’ve seen? Most common? - Common: fever, irritability, excessive crying.
- Severe: high fevers >104°F, seizures, full-body limpness, death, loss of consciousness, brain inflammation.
Worst-case outcome from insert or VAERS? How many deaths? Pfizer’s insert lists: apnea, seizures, SIDS, urticaria, anaphylaxis, death.
- VAERS: Hundreds of deaths attributed to PCV.
- Notably, SIDS and cardiorespiratory arrest frequently appear in temporal reports post-PCV.
Recent VAERS reports? Severity? Ongoing reports (2020–2024) show infant deaths within 48 hours, seizures, apnea, febrile convulsions. Most severe events happen after multi-shot visits (DTaP + Hep B + PCV + Rotavirus, etc.).
How many VAERS reports have you filed? Do you follow up? Doctors generally do not report unless required. VAERS reporting remains voluntary. Follow-up post-PCV is not standard. Subtle changes in behavior, tone, feeding, or alertness are often dismissed.
Will antibodies be tested before additional doses? Why a one-size-fits-all approach? No antibody testing is offered before giving the 4-shot PCV series. CDC mandates dosing without regard to health history, response, or environment.
Can you guarantee this vaccine won't cause long-term damage? No. The vaccine contains aluminum phosphate (~125 mcg per dose). Animal studies show aluminum migrates to the brain and can cause chronic inflammation. Long-term neurotoxicity has not been ruled out, and no study has tracked infant outcomes into adulthood.
Was this tested against a saline placebo? No true saline placebo. Trials used active comparators (older vaccines or other adjuvanted products). This masks adverse effects in comparative safety claims.
Do you treat unvaccinated patients? Ever advised against PCV? Rarely. Most doctors follow the schedule rigidly. Even in children with autoimmune disease, seizures, or mitochondrial risk, the recommendation remains unchanged.
If a patient has a serious adverse reaction, do you continue the series? Unless the child has a documented anaphylactic reaction, the schedule is almost always resumed. Even with post-vaccine hospitalization, many providers deny causation and proceed.
Can we walk through the insert and ingredients? - Contains: 13 pneumococcal serotypes, aluminum phosphate, polysorbate 80, and residual proteins.
- Listed risks: apnea, seizure, cardiorespiratory arrest, death.
- Insert notes higher risks in premature infants or those with unstable respiratory history.
How do you distinguish between coincidence and causation? Temporal proximity is rarely accepted as evidence. If a child dies or has seizures within 24 hours, pediatricians often claim coincidence — even if the event is on the insert. There is no standardized, mandatory method of assessment.
Any long-term studies comparing vaccinated vs. unvaccinated children? No long-term, independently conducted outcomes studies. No tracking of vaccinated children into adolescence for autoimmunity, allergy, or neurodevelopmental divergence.
Any concern over the growing vaccine schedule? PCV was added in 2000. Today, infants receive 3–4 PCV shots in their first year. Each shot adds to the cumulative aluminum and adjuvant load, a burden not tested cumulatively in clinical trials.
Have you noticed increases in asthma, eczema, allergies, neurodevelopmental disorders? Yes. These conditions have increased significantly since early 2000s. PCV coincides with a broader trend of early immune hyperstimulation. No study has definitively ruled out its role in triggering chronic inflammatory or allergic disorders.
If my child reacted severely, would you acknowledge it and report it? Most doctors would not. Liability is avoided by calling such events coincidental. Many parents report dismissal or gaslighting when concerns are raised.
Are you under pressure to maintain vaccination rates? Yes. Pediatric practices face pressure from insurance networks, quality reporting systems, and public health officials. Bonuses can be tied to vaccine compliance metrics.
Do you know how the Vaccine Injury Compensation Program works? Have any patients filed? PCV-related claims (especially death, encephalitis, seizures) have been paid. But doctors rarely initiate this process or inform parents. Filing requires legal effort, evidence, and must be completed within a specific window.